Nbt Bank N A Abbott Laboratories Transaction History

Nbt Bank N A

$1.39 Billion
Q2 2024

A detailed history of Nbt Bank N A transactions in Abbott Laboratories stock. As of the latest transaction made, Nbt Bank N A holds 119,237 shares of ABT stock, worth $13.7 Million. This represents 0.89% of its overall portfolio holdings.

Number of Shares

119,237

Previous 113,821 4.76%

Holding current value

$13.7 Million

Previous $12.9 Million 4.23%

% of portfolio

0.89%

Previous 0.96%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 30, 2024	BUY	$100.73 - $112.44 $545,553 - $608,975	5,416 Added 4.76%	119,237 $12.4 Million
Q1 2024 Apr 24, 2024	SELL	$109.52 - $120.96 $354,078 - $391,063	-3,233 Reduced 2.76%	113,821 $12.9 Million
Q4 2023 Feb 09, 2024	BUY	$90.19 - $110.4 $73,414 - $89,865	814 Added 0.7%	117,054 $12.9 Million
Q3 2023 Oct 26, 2023	BUY	$95.53 - $114.62 $5.24 Million - $6.29 Million	54,875 Added 89.42%	116,240 $11.3 Million
Q2 2023 Jul 24, 2023	SELL	$100.78 - $112.29 $216,475 - $241,198	-2,148 Reduced 3.38%	61,365 $6.69 Million
Q1 2023 May 02, 2023	SELL	$96.86 - $114.01 $211,154 - $248,541	-2,180 Reduced 3.32%	63,513 $6.43 Million
Q4 2022 Feb 10, 2023	SELL	$95.06 - $111.52 $126,714 - $148,656	-1,333 Reduced 1.99%	65,693 $7.21 Million
Q3 2022 Nov 08, 2022	SELL	$96.76 - $112.03 $79,052 - $91,528	-817 Reduced 1.2%	67,026 $6.49 Million
Q2 2022 Jul 26, 2022	BUY	$102.07 - $123.37 $31,335 - $37,874	307 Added 0.45%	67,843 $7.37 Million
Q1 2022 Apr 29, 2022	SELL	$114.02 - $139.04 $197,710 - $241,095	-1,734 Reduced 2.5%	67,536 $7.99 Million
Q4 2021 Jan 27, 2022	SELL	$115.53 - $141.46 $236,374 - $289,427	-2,046 Reduced 2.87%	69,270 $9.75 Million
Q3 2021 Oct 18, 2021	SELL	$116.66 - $129.06 $163,790 - $181,200	-1,404 Reduced 1.93%	71,316 $8.43 Million
Q2 2021 Jul 28, 2021	SELL	$105.79 - $124.53 $121,446 - $142,960	-1,148 Reduced 1.55%	72,720 $8.43 Million
Q1 2021 Apr 08, 2021	SELL	$108.84 - $128.23 $607,544 - $715,779	-5,582 Reduced 7.03%	73,868 $8.85 Million
Q4 2020 Jan 15, 2021	SELL	$105.0 - $114.42 $399,105 - $434,910	-3,801 Reduced 4.57%	79,450 $8.7 Million
Q3 2020 Oct 29, 2020	BUY	$91.64 - $111.29 $71,021 - $86,249	775 Added 0.94%	83,251 $9.06 Million
Q2 2020 Jul 22, 2020	SELL	$76.57 - $98.0 $266,233 - $340,746	-3,477 Reduced 4.05%	82,476 $7.54 Million
Q1 2020 Apr 23, 2020	SELL	$62.82 - $91.86 $157,929 - $230,936	-2,514 Reduced 2.84%	85,953 $6.78 Million
Q4 2019 Feb 05, 2020	SELL	$78.51 - $87.4 $114,153 - $127,079	-1,454 Reduced 1.62%	88,467 $7.69 Million
Q3 2019 Nov 12, 2019	BUY	$81.84 - $88.74 $29,380 - $31,857	359 Added 0.4%	89,921 $7.52 Million
Q2 2019 Aug 07, 2019	SELL	$72.88 - $85.0 $32,868 - $38,335	-451 Reduced 0.5%	89,562 $7.53 Million
Q1 2019 May 06, 2019	SELL	$66.22 - $80.06 $44,234 - $53,480	-668 Reduced 0.74%	90,013 $7.2 Million
Q4 2018 Feb 14, 2019	SELL	$65.56 - $74.27 $409,291 - $463,667	-6,243 Reduced 6.44%	90,681 $6.56 Million
Q3 2018 Nov 09, 2018	SELL	$60.81 - $73.36 $300,340 - $362,325	-4,939 Reduced 4.85%	96,924 $7.11 Million
Q2 2018 Jul 31, 2018	SELL	$57.57 - $63.54 $469,022 - $517,660	-8,147 Reduced 7.41%	101,863 $6.21 Million
Q1 2018 May 22, 2018	SELL	$56.27 - $63.62 $104,831 - $118,524	-1,863 Reduced 1.67%	110,010 $6.59 Million
Q4 2017 Feb 14, 2018	SELL	$53.68 - $57.47 $382,792 - $409,818	-7,131 Reduced 5.99%	111,873 $6.39 Million
Q3 2017 Nov 07, 2017	SELL	$48.06 - $53.64 $3,460 - $3,862	-72 Reduced 0.06%	119,004 $6.35 Million
Q2 2017 Aug 08, 2017	BUY	N/A	119,076	119,076 $5.79 Million

Others Institutions Holding ABT

# of Institutions

3,181

Shares Held

1.33B

Call Options Held

8.62M

Put Options Held

7.18M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $202B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nbt Bank N A , based on Form 13F filings with the SEC.

News

Stay updated on Nbt Bank N A with notifications on news.

Account